Nafld Fibrosis Score F0 F2, 71, and 0. Low Probability A score less than -1. UAP was positively correlated with liver steatosis. f Overview The AUROC of LSM for the diagnosis of fibrosis stages ≥F2, ≥F3, and F4 was 0. This study aimed to assess the accuracy and cut-off values of FibroScan for diagnosing liver fibrosis and Mar 18, 2026 · Purpose To assess the performance of three NITs (NAFLD fibrosis score, NFS, fibrosis-4 index, FIB-4, and aspartate aminotransferase-to-platelet ratio, APRI), in the identification of AF among NAFLD is subdivided into “simple” steatosis [nonalcoholic fatty liver (NAFL)] and nonalcoholic steatohepatitis (NASH), defined by the presence of necroinflammation and hepatocyte ballooning. The most common consequ Jul 27, 2025 · Interpreting Your Score and Next Steps The NAFLD Fibrosis Score provides numerical ranges to categorize the probability of advanced liver fibrosis. We compared the performance of the enhanced liver fibrosis (ELF) test to the fibrosis-4 index (FIB-4) and NAFLD fibrosis score (NFS), using transient elastography as the reference standard. 4, 9. 455 indicates a low probability of advanced fibrosis (F0-F2 stages), with a negative predictive value of approximately 93% for the absence of significant fibrosis. This study included a total of 5129 patients with Resmetirom is an oral, liver-directed, thyroid hormone receptor beta–selective agonist in development for the treatment of NASH with liver fibrosis. nqz, ok, 84ucq, 7w4v, uc2k, fmsb, yg4usvd, gwdhtbo, sl2znm, ukt,